Real-world data show Novartis drug Promacta® improves outcomes for ITP patients compared to other second-line therapies

Real-world data show Novartis drug Promacta® improves outcomes for ITP patients compared to other second-line therapies

Dec 02, 2018
Source URL: https://qa1.novartis.us/news/media-releases/real-world-data-show-novartis-drug-promacta-improves-outcomes-itp-patients-compared-other-second-line-therapies-0

List of links present in page
  1. https://qa1.novartis.us/news/media-releases/real-world-data-show-novartis-drug-promacta-improves-outcomes-itp-patients-compared-other-second-line-therapies-0